Antihypertensive medication non-adherence and its determinants among patients on follow up in public hospitals in Northern Ethiopia
DOI:
https://doi.org/10.5455/2349-3259.ijct20141103Keywords:
Antihypertensive, Non-adherence, Determinants, ARH, MGHAbstract
Background: Adherence to pharmacological treatment for hypertension is considered a key factor in guaranteeing successful therapy outcomes. Non-adherence to antihypertensive therapy can be determined by demographic, drug related, disease related and setting related factors. The primary aim of this study was to investigate antihypertensive medication non-adherence and its determinants among patients on follow up in Ayder referral hospital and Mekelle general hospital.
Methods: A prospective cross-sectional study was conducted in Ayder Referral Hospital (ARH) and Mekelle General Hospital (MGH) from May to June, 2013. A total of 121 patients were interviewed with a structured standard questionnaire and patient medication charts were reviewed. The questionnaire contained of demographic questions, the 8-item Morisky medication adherence scale (MMAS) and questions about characteristics of hypertension and its therapy. The data collected were cleaned, entered and analyzed using Statistical Package for Social Science (SPSS) version 16 for windows with 95% confidence interval and P value <0.05.
Results: Around one fourth (26.4%) of the study participants were found to be non-adherent to their treatment. Family support on adherence (AOR = 0.170, 95%CI = 0.030-0.905), spot blood pressure (AOR = 0.052, 95%CI = 0.003-0.242), place of patient residence (AOR = 0.184, 95%CI =0.024-0.597) and hypertension related complications (AOR = 21.737, 95%CI = 1.568-418.428) were found significantly and strongly associated with treatment non-adherence.
Conclusions: A quarter of the participants of this study were completely non-adherent and only around half of them were adherent to their medications. The absence of family support, being at the prehypertension class of blood pressure, living in Mekelle city and presence of hypertensive heart disease were shown to decrease adherence to antihypertensive medications. Therefore, health care professionals should be adequately trained and resourced to offer proper counseling to hypertensive patients on their medication and disease conditions.References
Rampal L, Rampal S, Azhar MZ, Rahman AR. Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16440 subjects. Public Health. 2008;122(1):11-8.
Rodgers A, Lawes C, MacMahon S. Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl. 2000;18(1):S3-6.
Eduardo S, Avenue A. Adherence to long term therapies evidence for action. WHO, 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence_report/en/.
Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475-85.
Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011.
Felkey BG. Adherence screening and monitoring. Am Pharm. 1995 Jul;NS35(7):42-51.
Meichenbaum D, Turk DC. Facilitating treatment adherence. In: Meichenbaum D, Turk DC. A, eds. Practitioner’s Guidebook. New York, NY: Plenum Press; 1987: 20.
Haruna AJ. Adherence to anti-hypertensive medication regimens among patients attending the G.P.H.A. Hospital in Takoradi - Ghana, 2006. Available at: http://ir.knust.edu.gh/bitstream/123456789/677/1/HARUNA%20AHMED%20JAMBEDU.pdf.
Fatmah A, Xiang-Yu H, Ignacio C. Factors affecting antihypertensive treatment adherence: a Saudi Arabian perspective. Clin Med Diagn. 2012;2(4):27-32.
Hayden B. Bosworth. Medication adherence: making the case for increased awareness, 2012. Available at: http://www.scriptyourfuture.org/wp-content/uploads/2014/02/NCLDuke_BriefingPaper_FINAL.pdf.
Horowitz RI Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990;336:542-5.
Ambaw AD, Alemie GA, W/Yohannes SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar hospital, Northwest Ethiopia. BMC Public Health. 2012;12:282.
NEHI Publication. Thinking outside the pillbox. A system-wide approach to improving patient medication adherence for chronic disease, 2009. Available at: http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease. Accessed 2 April 2013.
Sabaté E. Adherence to long-term therapies: evidence for action. World Health Organization, 2003. Available at: http://apps.who.int/medicinedocs/en/d/Js4883e/6.1.3.html. Accessed 2 April 2013.
Anthony H, Valinsky L, Inbar Z, Gabriel C, Varda S. Perceptions of hypertension treatment among patients with and without diabetes. BMC Fam Pract. 2012;13:24.
Tigray Tourism. Quick facts about Mekelle and its outskirts, 2013. Available at: http://www.tigraitourism.com/index.php/mekelle-and-autskirts. Accessed 17 April 2013.
College of Health Sciences. The Ayder referral hospital, 2013. Available at: http://www.mu.edu.et/chs/index.php/ayder-referral-hospital. Accessed 17 April 2013.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
Ramli A, AhmadNur S, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence. 2012;6:613-22.
Bello SI. Adherence and generic substitution among hypertensive patients in a specialist hospital, Nigeria. Glob Adv Res J Med Med Sci. 2012;1(1)008-16.
Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One. 2007;2(3):e280.
Brigitte R Martins dos S, Juliana T, Débora G, Reynaldo MG, Boni Y, Cicera CVA. Blood pressure levels and adherence to treatment of hypertensive patients, users of a school pharmacy. Braz J Pharm Sci. 2010;46(3):421-30.
Timothy JC. Adherence to hypertension management recommendations for patient follow-up care and lifestyle modifications made by military healthcare providers, May 2000. Available at: http://www.dtic.mil/get-tr-doc/pdf?AD=ADA421146.
J. M. Flack, S. V. Novikov, C. M. Ferrario. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J.1996;17(Suppl A):16-20.
Andrea QU, Amaury LF. Adherence to drug treatment in hypertensive patients on the family health program. Brazilian J Pharm Sci. 2010;46(4):811-8.
